Glycaemic targets, HbA1c and continuous glucose monitoring
- Follow-up and treatment
There is no single «good sugar» for everyone. A fit 40-year-old and a frail 85-year-old need different targets, and a sensor shows what HbA1c hides.
What it is
HbA1c reflects the average glucose of the past two to three months. For most non-pregnant adults the target is below 7% (53 mmol/mol); a lower target (below 6.5%) suits some young patients if it can be reached without hypoglycaemia, and a higher one (below 8%) suits people with limited life expectancy, frailty, advanced complications or a history of severe hypoglycaemia. Day-to-day control is checked by capillary glucose (usual targets before meals 80–130 mg/dL and below 180 mg/dL one to two hours after eating) or by continuous glucose monitoring (CGM), which measures interstitial glucose every few minutes. CGM is summarised as time in range (70–180 mg/dL; target more than 70% of the day), time below range (below 70 mg/dL less than 4%, below 54 mg/dL less than 1%) and time above range, and it is recommended for everyone on insulin.
What to know
- Targets are individual: younger, healthy, short duration, no hypoglycaemia → lower target; frail, short life expectancy, severe hypoglycaemia, advanced complications → higher target.
- Older adults: healthy with few illnesses, below 7.0–7.5%; complex or intermediate health, below 8.0%; very complex or poor health, avoid hypoglycaemia and symptomatic hyperglycaemia rather than aiming at a number.
- Pregnancy: tighter targets (below 6% if reachable without hypoglycaemia, otherwise below 7%), because the fetus is exposed to every high.
- Children and adolescents: below 7% for most, with CGM metrics as for adults.
- An HbA1c of 7% corresponds to an average glucose of about 154 mg/dL (8.6 mmol/L).
- CGM targets for most adults: time in range above 70%, time below 70 mg/dL under 4%, below 54 mg/dL under 1%, above 180 mg/dL under 25%; for older or high-risk adults, time in range above 50% and time below 70 mg/dL under 1%.
- Glucose variability (coefficient of variation) at or below 36% marks stable control.
- The glucose management indicator (GMI) is an HbA1c estimated from CGM; a gap between GMI and laboratory HbA1c suggests a red-cell or haemoglobin problem.
- HbA1c is unreliable in anaemia, haemoglobin variants, recent transfusion or bleeding, pregnancy and advanced kidney disease: use glucose or CGM instead.
- Sensor readings lag blood glucose by several minutes, most when glucose changes fast; confirm with a fingerstick when symptoms and the sensor disagree.
Choosing the HbA1c target
| Patient | Usual HbA1c target | Main concern |
|---|---|---|
| Most non-pregnant adults | Below 7% | Prevent small-vessel complications |
| Young, healthy, short duration, no hypoglycaemia | Below 6.5% if safe | Long life ahead to accumulate damage |
| Healthy older adult | Below 7.0–7.5% | Balance benefit and hypoglycaemia |
| Frail, many illnesses, short life expectancy, severe hypoglycaemia | Below 8%, or avoid symptoms | Hypoglycaemia, falls, burden of treatment |
| Pregnancy | Below 6% if safe, otherwise below 7% | Fetal exposure to hyperglycaemia |
In the clinic
- A falling HbA1c with new night-time confusion in an older patient is not a success: look for hypoglycaemia with CGM or night checks.
- A high HbA1c with normal fingerstick readings suggests the patient tests only at good moments, a meter problem, or high readings after meals that are never checked.
- People with type 2 diabetes on non-insulin drugs that do not cause hypoglycaemia rarely need daily fingersticks; testing is useful when starting or changing treatment, during illness, or to learn food effects.
Next step / Initial management
- HbA1c every three months when not at target or after a change in treatment, and at least twice a year when stable.
- Agree an individual HbA1c target with each patient and write it in the record; review it as health changes.
- Offer CGM to everyone on insulin; review the ambulatory glucose profile at each visit, looking first at time below range, then time in range.
- When HbA1c and glucose readings disagree, check haemoglobin, kidney function and haemoglobin variants, and rely on glucose or CGM.
- Refer to endocrinology persistent time below range despite changes, hypoglycaemia unawareness, or pregnancy with diabetes.
Common traps
- Lower HbA1c is always better: below an individual target, extra lowering mainly adds hypoglycaemia, and in frail or older patients that raises falls and deaths.
- An HbA1c at target means control is fine: the same average can hide frequent lows and highs, which only CGM or structured testing shows.
- Sensor and fingerstick should match exactly: interstitial glucose lags blood glucose, most when it is changing fast after meals or exercise.
- HbA1c works the same in everyone: anaemia, haemoglobin variants, pregnancy and kidney failure shift it independently of glucose.
- Time in range above 70% is the target for every adult: for older and high-risk adults the priority is time below range, so a lower time in range is accepted.
Test yourself
Think of the answer, then tap the question to see it.
An 84-year-old with dementia on insulin has an HbA1c of 6.4% and recent falls. What do you do with the target?
Relax it: for very complex health the goal is avoiding hypoglycaemia and symptoms, not a low number. Simplify treatment and check for lows.
Two patients have an HbA1c of 7.2%. One has a time in range of 80%, the other 45% with 8% below range. Who needs urgent change?
The second: the same average hides frequent highs and dangerous lows. Time below range above 4% needs treatment changed first to prevent severe hypoglycaemia.
A patient's CGM indicator (GMI) is 7.8% but the laboratory HbA1c is 6.2%. What might explain it?
A shortened red-cell lifespan (haemolysis, bleeding, kidney disease with erythropoietin) or a haemoglobin variant falsely lowering HbA1c.
Elsewhere in DurgiPedia
- Physiology of diabetes and ketoacidosis
- Diabetes in pregnancy: screening, targets and timing of birth
- Diabetes self-management teaching before discharge: monitoring, food, activity and sick-day rules
Connections
In Pharmacology3
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Hemoglobin A1C (StatPearls (NCBI Bookshelf), 2025); Type 2 Diabetes (StatPearls (NCBI Bookshelf), 2023); Type 1 Diabetes (StatPearls (NCBI Bookshelf), 2024); Hypoglycemia (StatPearls (NCBI Bookshelf), 2022).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
